comparemela.com

Page 7 - Sid Viswanathan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

eMed and Truepill Partner to Distribute COVID-19 Rapid At-Home BinaxNOW Antigen Test

eMed and Truepill Partner to Distribute COVID-19 Rapid At-Home BinaxNOW Antigen Test
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Truepill rolls out suite of COVID-19 diagnostics, digital tools for the employer market

Photo credit: Truepill  Today there are still a lot of questions around getting the workforce back into the office, clinic or manufacturing site. Digital health company Truepill is looking to address this issue by teaming up with the Health Transformation Alliance to offer Truepill s new employer-focused suite of COVID-19-focused diagnostics and digital tools to the former s members. Truepill s new program will incorporate at-home or worksite COVID-19 testing, virtual care, medication delivery and contact tracing, as well as an employer-facing platform to help clients manage the workforce. If you imagine buying a new home, and you have to remodel it, and you are doing it yourself, Sid Viswanathan, cofounder and president of Truepill, told

Gauss Partners with Truepill in Strategic Effort to Deliver At-Home COVID-19 Rapid Testing to Millions

Gauss Partners with Truepill in Strategic Effort to Deliver At-Home COVID-19 Rapid Testing to Millions Share Article MENLO PARK, Calif. (PRWEB) December 23, 2020 Gauss, a leading developer of computer vision-aided diagnostics for healthcare, today announced its partnership with Truepill™, the digital health platform powering consumer health experiences through its API-connected infrastructure, to help facilitate the delivery of at-home COVID-19 rapid tests to customers’ doorsteps. The partnership supports Gauss’s efforts to scale manufacturing and operations in advance of commercialization of its smartphone-powered at-home COVID-19 rapid antigen test, which has been submitted to the Food and Drug Administration (FDA) for Emergency Use Authorization (EUA).

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.